- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A PCT complained an Abbott representative missed a rebooked appointment without explanation. The Panel found the second appointment was likely made for…
A mental health nurse challenged a Risperdal mailing as stigmatising and queried mailing list ethics and rep visit frequency. The Panel found…
Complaint about promotion of Juvederm Ultra. PMCPA concluded no breach because the matter was outwith the scope of the ABPI Code (2008).…
PMCPA case AUTH/2401/4/11 (Anonymous v Meda) about promotion of Rhinolast. The matter was ruled outwith the scope of the ABPI Code; no…
Anonymous HCP alleged AbbVie rep interrogated clinicians about prescribing and immunising twins outside JCVI guidance and licence at a BPD Masterclass. Panel…
At a UK melanoma congress, organisers mistakenly printed a digital Keytruda app ad onto a pillar. The print lacked prescribing information and…
PMCPA case AUTH/2907/11/16 (Director v Takeda) concerning clinical trial disclosure for Vipidia. Outcome: No breach and matter was outwith the scope of…
PMCPA found Bayer’s Xarelto site did not promote to the public, but a patient/public page invited people to contact medical information for…
GSK admitted two Avamys online banner ads had a non-proprietary name that was not readily readable in the HTML files and not…
After inter-company dialogue, Ipsen’s Dysport messaging (‘a toxin with a long-lasting effect’) was held to imply an unsubstantiated duration advantage. Appeal Board…
An employee complaint upheld after Accord’s public LinkedIn post referred positively to three prescription-only medicines as “vital COVID-19 medicines”, amounting to promotion…
Pulse Daily email linked to a sponsored ‘education hub’ that the Panel said promoted Gaviscon for prescription. Breaches included disguised promotion, unclear…
Anonymous complainant alleged Colonis’ public website promoted prescription-only medicines. Panel found the pages were non-promotional reference information with no product claims; no…
A Reletrans (buprenorphine) journal cover outsert became visible when ~3,300 copies were mailed in transparent polywrap. PMCPA ruled promotion of a POM…
After giving an undertaking to stop using misleading Meriofert vs Menopur claims, Pharmasure left similar claims live on its UK website. PMCPA…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.